QQ客服 官方微博 反馈留言

	Comparison of paclitaxel in combination with cisplatin (TP), carboplatin (TC) or fluorouracil (TF) concurrent with radiotherapy for patients with local advanced oesophageal squamous cell carcinoma: a three-arm phase III randomized trial (ESO-Shanghai 2)
	Ai, Dashan; Chen, Yun; Liu, Qi; Zhang, Junhua; Deng, Jiaying; Zhu, Hanting; Ren, Wenjia; Zheng, Xiangpeng; Li, Yunhai; Wei, Shihong
刊名	BMJ OPEN
	2018
卷号	8期号:10
ISSN号	2044-6055
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3599818
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Ai, Dashan,Chen, Yun,Liu, Qi,et al. Comparison of paclitaxel in combination with cisplatin (TP), carboplatin (TC) or fluorouracil (TF) concurrent with radiotherapy for patients with local advanced oesophageal squamous cell carcinoma: a three-arm phase III randomized trial (ESO-Shanghai 2)[J]. BMJ OPEN,2018,8(10).
APA	Ai, Dashan.,Chen, Yun.,Liu, Qi.,Zhang, Junhua.,Deng, Jiaying.,...&Badakhshi, Harun.(2018).Comparison of paclitaxel in combination with cisplatin (TP), carboplatin (TC) or fluorouracil (TF) concurrent with radiotherapy for patients with local advanced oesophageal squamous cell carcinoma: a three-arm phase III randomized trial (ESO-Shanghai 2).BMJ OPEN,8(10).
MLA	Ai, Dashan,et al."Comparison of paclitaxel in combination with cisplatin (TP), carboplatin (TC) or fluorouracil (TF) concurrent with radiotherapy for patients with local advanced oesophageal squamous cell carcinoma: a three-arm phase III randomized trial (ESO-Shanghai 2)".BMJ OPEN 8.10(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。